Sarah Ogle
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Sarah Ogle has a total of 5 co-authors. Here are the top co-authors by number of shared publications:
- Alexander M. Kaizer
Department of Biostatistics and Informatics, School of Public Health, University of Colorado Anschutz Medical Campus, Aurora, USA
1 shared publication - Ann M. Kulungowski
Children's Hospital Colorado, 13123 East 16th Ave. Box B323, Aurora, CO 80045
1 shared publication - Emily H. Cooper
Center for Children’s Surgery, Research Outcomes in Children’s Surgery, Children’s Hospital Colorado, University of Colorado School of Medicine, Aurora, USA
1 shared publication - Nell T. Weber
Division of Pediatric Surgery, Children’s Hospital Colorado, University of Colorado School of Medicine, Aurora, USA
1 shared publication - Shannon N. Acker
Research Outcomes in Children's Surgery, Children's Hospital Colorado, University of Colorado School of Medicine, Aurora, CO, USA; Department of Surgery, Division of Pediatric Surgery, University of Colorado School of Medicine, Aurora, CO, USA
1 shared publication
Latest Publications
- 11 March 2024
- Published by Springer Nature in Pediatric Surgery International
- Vol. 40 (1) , 1-6
Low-risk pneumatosis intestinalis in the pediatric surgical population
Background Pneumatosis intestinalis (PI, presence of air in bowel wall) develops in a variety of settings and due to a variety of insults which is then characterized by varying severity and clinical course. Anecdotally, many of these cases are benign with few clinical sequelae; however, we lack evidence-based guidelines to help guide management of such lower-risk cases. We aimed to describe the clinical entity of low-risk PI, characterize the population of children who develop this form of PI, determine if management approach or clinical outcomes differed depending on the managing physician’s field of practice, and finally determine if a shortened course of NPO and antibiotics was safe in the population of children with low-risk PI. Methods We performed a retrospective review of all children over age 1 year treated at Children’s Hospital Colorado (CHCO), between 2009 and 2019 with a diagnosis of PI who did not also have a diagnosis of cancer or history of bone marrow transplant (BMT). Data including demographic variables, clinical course, and outcomes were obtained from the electronic medical record. Low-risk criteria included no need for ICU admission, vasopressor use, or urgent surgical intervention. Results Ninety-one children were treated for their first episode of PI during the study period, 72 of whom met our low-risk criteria. Among the low-risk group, rates of complications including hemodynamic decompensation during treatment, PI recurrence, Clostridium difficile colitis, and death did not differ between those who received 3 days or less of antibiotics and those who received more than 3 days of antibiotics. Outcomes also did not differ between children cared for by surgeons or pediatricians. Conclusions Here, we define low-risk PI as that which occurs in children over age 1 who do not have a prior diagnosis of cancer or prior BMT and who do not require ICU admission, vasopressor administration, or urgent surgical intervention. It is likely safe to treat these children with only 3 days of antibiotic therapy and NPO. Level of evidence Level III.
- 11 March 2024
- Published by Springer Nature in Pediatric Surgery International
- Vol. 40 (1) , 1-6
Low-risk pneumatosis intestinalis in the pediatric surgical population
Background Pneumatosis intestinalis (PI, presence of air in bowel wall) develops in a variety of settings and due to a variety of insults which is then characterized by varying severity and clinical course. Anecdotally, many of these cases are benign with few clinical sequelae; however, we lack evidence-based guidelines to help guide management of such lower-risk cases. We aimed to describe the clinical entity of low-risk PI, characterize the population of children who develop this form of PI, determine if management approach or clinical outcomes differed depending on the managing physician’s field of practice, and finally determine if a shortened course of NPO and antibiotics was safe in the population of children with low-risk PI. Methods We performed a retrospective review of all children over age 1 year treated at Children’s Hospital Colorado (CHCO), between 2009 and 2019 with a diagnosis of PI who did not also have a diagnosis of cancer or history of bone marrow transplant (BMT). Data including demographic variables, clinical course, and outcomes were obtained from the electronic medical record. Low-risk criteria included no need for ICU admission, vasopressor use, or urgent surgical intervention. Results Ninety-one children were treated for their first episode of PI during the study period, 72 of whom met our low-risk criteria. Among the low-risk group, rates of complications including hemodynamic decompensation during treatment, PI recurrence, Clostridium difficile colitis, and death did not differ between those who received 3 days or less of antibiotics and those who received more than 3 days of antibiotics. Outcomes also did not differ between children cared for by surgeons or pediatricians. Conclusions Here, we define low-risk PI as that which occurs in children over age 1 who do not have a prior diagnosis of cancer or prior BMT and who do not require ICU admission, vasopressor administration, or urgent surgical intervention. It is likely safe to treat these children with only 3 days of antibiotic therapy and NPO. Level of evidence Level III.